ā”AstraZeneca Monoclonal Antibody Therapy AZD7442 Fails to Prevent COVID-19 Symptoms
By IANS
British-Swedish biopharmaceutical company AstraZeneca on Tuesday stated that its monoclonal antibody treatment failed to prevent the Covid-19 symptoms in individuals already exposed to the virus.